Khan I, Saeed K and Khan I: Nanoparticles: Properties, applications and toxicities. Arab J Chem. 12:908–931. 2019.

Haleem A, Javaid M, Singh RP, Rab S and Suman R: Applications of nanotechnology in medical field: A brief review. Glob Health J. 7:70–77. 2023.

Wang L, Hu C and Shao L: The antimicrobial activity of nanoparticles: Present situation and prospects for the future. Int J Nanomedicine. 12:1227–1249. 2017.PubMed/NCBI View Article : Google Scholar

Sekiya T, Ohno M, Nomura N, Handabile C, Shingai M, Jackson DC, Brown LE and Kida H: Selecting and using the appropriate influenza vaccine for each individual. Viruses. 13(971)2021.PubMed/NCBI View Article : Google Scholar

Sarkar J, Das S, Aich S, Bhattacharyya P and Acharya K: Antiviral potential of nanoparticles for the treatment of Coronavirus infections. J Trace Elem Med Biol. 72(126977)2022.PubMed/NCBI View Article : Google Scholar

Moreira EA, Yamauchi Y and Matthias P: How influenza virus uses host cell pathways during uncoating. Cells. 10(1722)2021.PubMed/NCBI View Article : Google Scholar

Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG and García-Sastre A: Influenza. Nat Rev Dis Primer. 4(3)2018.PubMed/NCBI View Article : Google Scholar

To J and Torres J: Viroporins in the influenza virus. Cells. 8(654)2019.PubMed/NCBI View Article : Google Scholar

Park JE and Ryu Y: Transmissibility and severity of influenza virus by subtype. Infect Genet Evol. 65:288–292. 2018.PubMed/NCBI View Article : Google Scholar

Hutchinson EC: Influenza virus. Trends Microbiol. 26:809–810. 2018.PubMed/NCBI View Article : Google Scholar

Gaitonde DY, Moore FC and Morgan MK: Influenza: Diagnosis and treatment. Am Fam Physician. 100:751–758. 2019.PubMed/NCBI

Centers for Disease Control and Prevention (CDC): Antiviral drugs for seasonal influenza. CDC, Atlanta, GA, 2022.

Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V and Ebrahimpour S: A brief review of influenza virus infection. J Med Virol. 93:4638–4646. 2021.PubMed/NCBI View Article : Google Scholar

Wieczorek K, Szutkowska B and Kierzek E: Anti-influenza strategies based on nanoparticle applications. Pathogens. 9(1020)2020.PubMed/NCBI View Article : Google Scholar

Ghaffari H, Tavakoli A, Moradi A, Tabarraei A, Bokharaei-Salim F, Zahmatkeshan M, Farahmand M, Javanmard D, Kiani SJ, Esghaei M, et al: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: Another emerging application of nanomedicine. J Biomed Sci. 26(70)2019.PubMed/NCBI View Article : Google Scholar

Kheirollahpour M, Mehrabi M, Dounighi NM, Mohammadi M and Masoudi A: Nanoparticles and vaccine development. Pharm Nanotechnol. 8:6–21. 2020.PubMed/NCBI View Article : Google Scholar

Ielo I, Rando G, Giacobello F, Sfameni S, Castellano A, Galletta M, Drommi D, Rosace G and Plutino MR: Synthesis, chemical-physical characterization, and biomedical applications of functional gold nanoparticles: A review. Molecules. 26(5823)2021.PubMed/NCBI View Article : Google Scholar

Salazar-González JA, González-Ortega O and Rosales-Mendoza S: Gold nanoparticles and vaccine development. Expert Rev Vaccines. 14:1197–1211. 2015.PubMed/NCBI View Article : Google Scholar

Bowman MC, Ballard TE, Ackerson CJ, Feldheim DL, Margolis DM and Melander C: Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc. 130:6896–6897. 2008.PubMed/NCBI View Article : Google Scholar

Papp I, Sieben C, Ludwig K, Roskamp M, Böttcher C, Schlecht S, Herrmann A and Haag R: Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. Small. 6:2900–2906. 2010.PubMed/NCBI View Article : Google Scholar

Mikhailova EO: Gold nanoparticles: Biosynthesis and potential of biomedical application. J Funct Biomater. 12(70)2021.PubMed/NCBI View Article : Google Scholar

Li F, Huang Q, Zhou Z, Guan Q, Ye F, Huang B, Guo W and Liang XJ: Gold nanoparticles combat enveloped RNA virus by affecting organelle dynamics. Signal Transduct Target Ther. 8(285)2023.PubMed/NCBI View Article : Google Scholar

Wang C, Zhu W, Luo Y and Wang BZ: Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity. Nanomedicine. 14:1349–1360. 2018.PubMed/NCBI View Article : Google Scholar

Kim J, Yeom M, Lee T, Kim HO, Na W, Kang A, Lim JW, Park G, Park C, Song D and Haam S: Porous gold nanoparticles for attenuating infectivity of influenza A virus. J Nanobiotechnology. 18(54)2020.PubMed/NCBI View Article : Google Scholar

Xia Q, Huang J, Feng Q, Chen X, Liu X, Li X, Zhang T, Xiao S, Li H, Zhong Z and Xiao K: Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles. Int J Nanomedicine. 14:6957–6970. 2019.PubMed/NCBI View Article : Google Scholar

Bimler L, Song AY, Le DT, Murphy Schafer A and Paust S: AuNP-M2e + sCpG vaccination of juvenile mice generates lifelong protective immunity to influenza A virus infection. Immun Ageing. 16(23)2019.PubMed/NCBI View Article : Google Scholar

Tao W, Hurst BL, Shakya AK, Uddin MJ, Ingrole RS, Hernandez-Sanabria M, Arya RP, Bimler L, Paust S, Tarbet EB and Gill HS: Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses. Antiviral Res. 141:62–72. 2017.PubMed/NCBI View Article : Google Scholar

Tazaki T, Tabata K, Ainai A, Ohara Y, Kobayashi S, Ninomiya T, Orba Y, Mitomo H, Nakano T, Hasegawa H, et al: Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines. RSC Adv. 8:16527–16536. 2018.PubMed/NCBI View Article : Google Scholar

Aarreberg LD, Esser-Nobis K, Driscoll C, Shuvarikov A, Roby JA and Gale M Jr: Interleukin-1β induces mtDNA release to activate innate immune signaling via cGAS-STING. Mol Cell. 74:801–815.e6. 2019.PubMed/NCBI View Article : Google Scholar

Johnston SC, Lin KL, Connor JH, Ruthel G, Goff A and Hensley LE: In vitro inhibition of monkeypox virus production and spread by interferon-β. Virol J. 9(5)2012.PubMed/NCBI View Article : Google Scholar

Puthothu B, Bierbaum S, Kopp MV, Forster J, Heinze J, Weckmann M, Krueger M and Heinzmann A: Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma. Pediatr Allergy Immunol. 20:157–163. 2009.PubMed/NCBI View Article : Google Scholar

Sun Y, Jiang X, Liu Y, Liu D, Chen C, Lu C, Zhuang S, Kumar A and Liu J: Recent advances in Cu(II)/Cu(I)-MOFs based nano-platforms for developing new nano-medicines. J Inorg Biochem. 225(111599)2021.PubMed/NCBI View Article : Google Scholar

Grigore ME, Biscu ER, Holban AM, Gestal MC and Grumezescu AM: Methods of synthesis, properties and biomedical applications of CuO nanoparticles. Pharmaceuticals (Basel). 9(75)2016.PubMed/NCBI View Article : Google Scholar

Chang YN, Zhang M, Xia L, Zhang J and Xing G: The toxic effects and mechanisms of CuO and ZnO nanoparticles. Materials (Basel). 5:2850–2871. 2012.

Ali ZI, Ghazy OA, Meligi G, Saleh HH and Bekhit M: Radiation-induced synthesis of copper/poly(vinyl alcohol) nanocomposites and their catalytic activity. Adv Polym Technol. 37:365–375. 2018.

Ermini ML and Voliani V: Antimicrobial nano-agents: The copper age. ACS Nano. 15:6008–6029. 2021.PubMed/NCBI View Article : Google Scholar

Applerot G, Lellouche J, Lipovsky A, Nitzan Y, Lubart R, Gedanken A and Banin E: Understanding the antibacterial mechanism of CuO nanoparticles: Revealing the route of induced oxidative stress. Small. 8:3326–3337. 2012.PubMed/NCBI View Article : Google Scholar

Ha T, Pham TTM, Kim M, Kim YH, Park JH, Seo JH, Kim KM and Ha E: Antiviral activities of high energy E-beam induced copper nanoparticles against H1N1 influenza virus. Nanomaterials (Basel). 12(268)2022.PubMed/NCBI View Article : Google Scholar

Puchkova LV, Kiseleva IV, Polishchuk EV, Broggini M and Ilyechova EY: The crossroads between host copper metabolism and influenza infection. Int J Mol Sci. 22(5498)2021.PubMed/NCBI View Article : Google Scholar

Sportelli MC, Izzi M, Kukushkina EA, Hossain SI, Picca RA, Ditaranto N and Cioffi N: Can nanotechnology and materials science help the fight against SARS-CoV-2? Nanomaterials (Basel). 10(802)2020.PubMed/NCBI View Article : Google Scholar

Gurunathan S, Park JH, Han JW and Kim JH: Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: Targeting p53 for anticancer therapy. Int J Nanomedicine. 10:4203–4223. 2015.PubMed/NCBI View Article : Google Scholar

Lu L, Sun RWY, Chen R, Hui CK, Ho CM, Luk JM, Lau GK and Che CM: Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 13:253–262. 2008.PubMed/NCBI

Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V and Galdiero M: Silver nanoparticles as potential antiviral agents. Molecules. 16:8894–8918. 2011.PubMed/NCBI View Article : Google Scholar

Mori Y, Ono T, Miyahira Y, Nguyen VQ, Matsui T and Ishihara M: Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett. 8(93)2013.PubMed/NCBI View Article : Google Scholar

Feng F, Sakoda Y, Ohyanagi T, Nagahori N, Shibuya H, Okamastu M, Miura N, Kida H and Nishimura S: Novel thiosialosides tethered to metal nanoparticles as potent influenza A virus haemagglutinin blockers. Antivir Chem Chemother. 23:59–65. 2013.PubMed/NCBI View Article : Google Scholar

Morris D, Ansar M, Speshock J, Ivanciuc T, Qu Y, Casola A and Garofalo R: Antiviral and immunomodulatory activity of silver nanoparticles in experimental RSV infection. Viruses. 11(732)2019.PubMed/NCBI View Article : Google Scholar

Ratan ZA, Mashrur FR, Chhoan AP, Shahriar SM, Haidere MF, Runa NJ, Kim S, Kweon DH, Hosseinzadeh H and Cho JY: Silver nanoparticles as potential antiviral agents. Pharmaceutics. 13(2034)2021.PubMed/NCBI View Article : Google Scholar

Meineke R, Rimmelzwaan G and Elbahesh H: Influenza virus infections and cellular kinases. Viruses. 11(171)2019.PubMed/NCBI View Article : Google Scholar

Trefry JC and Wooley DP: Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism. J Biomed Nanotechnol. 9:1624–1635. 2013.PubMed/NCBI View Article : Google Scholar

Tripathi S, White MR and Hartshorn KL: The amazing innate immune response to influenza A virus infection. Innate Immun. 21:73–98. 2015.PubMed/NCBI View Article : Google Scholar

Xiang D, Zheng Y, Duan W, Li X, Yin J, Shigdar S, O'Connor ML, Marappan M, Zhao X, Miao Y, et al: Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J Nanomedicine. 8:4103–4113. 2013.PubMed/NCBI View Article : Google Scholar

Li Y, Lin Z, Zhao M, Xu T, Wang C, Hua L, Wang H, Xia H and Zhu B: Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways. ACS Appl Mater Interfaces. 8:24385–24393. 2016.PubMed/NCBI View Article : Google Scholar

Yang Y, Zhang M, Song H and Yu C: Silica-based nanoparticles for biomedical applications: From nanocarriers to biomodulators. Acc Chem Res. 53:1545–1556. 2020.PubMed/NCBI View Article : Google Scholar

Häffner SM, Parra-Ortiz E, Browning KL, Jørgensen E, Skoda MWA, Montis C, Li X, Berti D, Zhao D and Malmsten M: Membrane interactions of virus-like mesoporous silica nanoparticles. ACS Nano. 15:6787–6800. 2021.PubMed/NCBI View Article : Google Scholar

Maurer-Jones MA, Lin YS and Haynes CL: Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano. 4:3363–3373. 2010.PubMed/NCBI View Article : Google Scholar

Cheng K, El-Boubbou K and Landry CC: Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments. ACS Appl Mater Interfaces. 4:235–243. 2012.PubMed/NCBI View Article : Google Scholar

Tng DJH and Low JGH: Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses. Antiviral Res. 210(105488)2023.PubMed/NCBI View Article : Google Scholar

Neuhaus V, Schwarz K, Klee A, Seehase S, Förster C, Pfennig O, Jonigk D, Fieguth HG, Koch W, Warnecke G, et al: Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique. PLoS One. 8(e71728)2013.PubMed/NCBI View Article : Google Scholar

Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I and Tschopp J: Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci USA. 107:19449–19454. 2010.PubMed/NCBI View Article : Google Scholar

AbouAitah K, Swiderska-Sroda A, Kandeil A, Salman AMM, Wojnarowicz J, Ali MA, Opalinska A, Gierlotka S, Ciach T and Lojkowski W: Virucidal action against avian influenza H5N1 virus and immunomodulatory effects of nanoformulations consisting of mesoporous silica nanoparticles loaded with natural prodrugs. Int J Nanomedicine. 15:5181–5202. 2020.PubMed/NCBI View Article : Google Scholar

Wang H, Chen L, Li R, Lv C, Xu Y and Xiong Y: Polydopamine-coated mesoporous silica nanoparticles co-loaded with Ziyuglycoside I and Oseltamivir for synergistic treatment of viral pneumonia. Int J Pharm. 645(123412)2023.PubMed/NCBI View Article : Google Scholar

Lakshmipriya T and Gopinath SCB: 1-Introduction to nanoparticles and analytical devices. In: Nanoparticles in Analytical and Medical Devices. Gopinath SCB and Gang F (eds.) Elsevier, pp1-29, 2021.

Attia GH, Moemen YS, Youns M, Ibrahim AM, Abdou R and El Raey MA: Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2. Colloids Surf B Biointerfaces. 203(111724)2021.PubMed/NCBI View Article : Google Scholar

Singh TA, Sharma A, Tejwan N, Ghosh N, Das J and Sil PC: A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles. Adv Colloid Interface Sci. 295(102495)2021.PubMed/NCBI View Article : Google Scholar

Poon WL, Alenius H, Ndika J, Fortino V, Kolhinen V, Meščeriakovas A, Wang M, Greco D, Lähde A, Jokiniemi J, et al: Nano-sized zinc oxide and silver, but not titanium dioxide, induce innate and adaptive immunity and antiviral response in differentiated THP-1 cells. Nanotoxicology. 11:936–951. 2017.PubMed/NCBI View Article : Google Scholar

Mandal AK, Katuwal S, Tettey F, Gupta A, Bhattarai S, Jaisi S, Bhandari DP, Shah AK, Bhattarai N and Parajuli N: Current research on zinc oxide nanoparticles: Synthesis, Characterization, and biomedical applications. Nanomaterials (Basel). 12(3066)2022.PubMed/NCBI View Article : Google Scholar

te Velthuis AJW, van den Worm SHE, Sims AC, Baric RS, Snijder EJ and van Hemert MJ: Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 6(e1001176)2010.PubMed/NCBI View Article : Google Scholar

Imani SM, Ladouceur L, Marshall T, Maclachlan R, Soleymani L and Didar TF: Antimicrobial nanomaterials and coatings: Current mechanisms and future perspectives to control the spread of viruses including SARS-CoV-2. ACS Nano. 14:12341–12369. 2020.PubMed/NCBI View Article : Google Scholar

Shahabadi N, Zendehcheshm S and Khademi F: Selenium nanoparticles: Synthesis, in-vitro cytotoxicity, antioxidant activity and interaction studies with ct-DNA and HSA, HHb and Cyt c serum proteins. Biotechnol Rep (Amst). 30(e00615)2021.PubMed/NCBI View Article : Google Scholar

Zhang T, Qi M, Wu Q, Xiang P, Tang D and Li Q: Recent research progress on the synthesis and biological effects of selenium nanoparticles. Front Nutr. 10(1183487)2023.PubMed/NCBI View Article : Google Scholar

Ferro C, Florindo HF and Santos HA: Selenium nanoparticles for biomedical applications: From development and characterization to therapeutics. Adv Healthc Mater. 10(2100598)2021.PubMed/NCBI View Article : Google Scholar

Cheng Z, Zhi X, Sun G, Guo W, Huang Y, Sun W, Tian X, Zhao F and Hu K: Sodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell lines. J Med Virol. 88:653–663. 2016.PubMed/NCBI View Article : Google Scholar

Li Y, Lin Z, Guo M, Xia Y, Zhao M, Wang C, Xu T, Chen T and Zhu B: Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus. Int J Nanomedicine. 12:5733–5743. 2017.PubMed/NCBI View Article : Google Scholar

Kopel J, Fralick J and Reid TW: The potential antiviral effects of selenium nanoparticles and coated surfaces. Antibiotics (Basel). 11(1683)2022.PubMed/NCBI View Article : Google Scholar

Liu X, Chen D, Su J, Zheng R, Ning Z, Zhao M, Zhu B and Li Y: Selenium nanoparticles inhibited H1N1 influenza virus-induced apoptosis by ROS-mediated signaling pathways. RSC Adv. 12:3862–3870. 2022.PubMed/NCBI View Article : Google Scholar

Xu T, Lai J, Su J, Chen D, Zhao M, Li Y and Zhu B: Inhibition of H3N2 influenza virus induced apoptosis by selenium nanoparticles with chitosan through ROS-mediated signaling pathways. ACS Omega. 8:8473–8480. 2023.PubMed/NCBI View Article : Google Scholar

Banoth B and Cassel SL: Mitochondria in innate immune signaling. Transl Res. 202:52–68. 2018.PubMed/NCBI View Article : Google Scholar

Li Y, Lin Z, Guo M, Zhao M, Xia Y, Wang C, Xu T and Zhu B: Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways. Int J Nanomedicine. 13:2005–2016. 2018.PubMed/NCBI View Article : Google Scholar

Khanna M, Sharma S, Kumar B and Rajput R: Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development. Biomed Res Int. 2014(546274)2014.PubMed/NCBI View Article : Google Scholar

Cilento ME, Kirby KA and Sarafianos SG: Avoiding drug resistance in HIV reverse transcriptase. Chem Rev. 121:3271–3296. 2021.PubMed/NCBI View Article : Google Scholar

Draz MS and Shafiee H: Applications of gold nanoparticles in virus detection. Theranostics. 8:1985–2017. 2018.PubMed/NCBI View Article : Google Scholar

Zhang Z, Schepens B, Nuhn L, Saelens X, Schotsaert M, Callewaert N, De Rycke R, Zhang Q, Moins S, Benali S, et al: Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination. Chem Commun (Camb). 52:3352–3355. 2016.PubMed/NCBI View Article : Google Scholar

Corti D, Cameroni E, Guarino B, Kallewaard NL, Zhu Q and Lanzavecchia A: Tackling influenza with broadly neutralizing antibodies. Curr Opin Virol. 24:60–69. 2017.PubMed/NCBI View Article : Google Scholar

Joyce MG, Wheatley AK, Thomas PV, Chuang GY, Soto C, Bailer RT, Druz A, Georgiev IS, Gillespie RA, Kanekiyo M, et al: Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell. 166:609–623. 2016.PubMed/NCBI View Article : Google Scholar

Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R, Ekiert DC, Lee JH, Metlagel Z, Bujny MV, Jongeneelen M, et al: Highly conserved protective epitopes on influenza B viruses. Science. 337:1343–1348. 2012.PubMed/NCBI View Article : Google Scholar

Kang SM, Song JM and Compans RW: Novel vaccines against influenza viruses. Virus Res. 162:31–38. 2011.PubMed/NCBI View Article : Google Scholar

Nesovic LD, Roach CJ, Joshi G and Gill HS: Delivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles. Biomater Sci. 11:5859–5871. 2023.PubMed/NCBI View Article : Google Scholar

Chen L and Liang J: An overview of functional nanoparticles as novel emerging antiviral therapeutic agents. Mater Sci Eng C Mater Biol Appl. 112(110924)2020.PubMed/NCBI View Article : Google Scholar

Nagy A and Robbins NL: The hurdles of nanotoxicity in transplant nanomedicine. Nanomedicine (Lond). 14:2749–2762. 2019.PubMed/NCBI View Article : Google Scholar

Tagami T and Ozeki T: Recent trends in clinical trials related to carrier-based drugs. J Pharm Sci. 106:2219–2226. 2017.PubMed/NCBI View Article : Google Scholar

Gopal J, Muthu M and Sivanesan I: A comprehensive survey on the expediated anti-COVID-19 options enabled by metal complexes-tasks and trials. Molecules. 28(3354)2023.PubMed/NCBI View Article : Google Scholar

Abukabda AB, Stapleton PA and Nurkiewicz TR: Metal nanomaterial toxicity variations within the vascular system. Curr Environ Health Rep. 3:379–391. 2016.PubMed/NCBI View Article : Google Scholar